Navigation Links
Bond Laboratories' First Quarter Fiscal 2008 Sales Exceeding Internal Projections
Date:3/27/2008

SAN DIEGO, March 27 /PRNewswire-FirstCall/ -- Bond Laboratories (OTC Bulletin Board: BNLB) is pleased to announce that sales of its Fusion 6+ Hour Energy Shot, which began shipping at the beginning of this year, have exceeded the company's internal projections for each month of the first quarter of 2008.

Fusion's 6+ Hour Energy Shot was first introduced at the National Convenience Store show in Atlanta this past November, where it was voted "Best Tasting Shot". Fusion began shipping the first week in January. "We have been getting numerous inquiries from shareholders regarding our sales growth as well as the number of distribution partners we have currently established relationships with. I am pleased to announce we have exceeded our internal sales projections, as well as our anticipated list of distribution partners", said Eric Schick, President of Bond.

We will provide more detailed information as to our progress in April, after Bond Laboratories has had an opportunity to file its first quarterly report for 2008.

About Bond Laboratories:

Bond Laboratories is a premier marketer and manufacturer of nationally branded nutritional products. Bond has brought together a seasoned team of highly successful sales and marketing executives with considerable experience in the launch and development of many well known branded products. With our previous nutraceutical and pharmaceutical sales and management expertise, Bond Laboratories, Inc. is currently focused on developing proprietary products, as well as delivery platforms, that address the needs and concerns of today's consumer. For more information on Fusion(TM) Energy Products, interested persons can go to http://www.got-fusion.com.

Safe Harbor

Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward- looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management as well as assumptions made by and information currently available to the Company or its management.

Contact: Scott Landow Phone: 858.847.9000

sdlandow@bond-labs.com Fax: 858.847.9090


'/>"/>
SOURCE Bond Laboratories
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. STMicroelectronics and Veredus Laboratories Launch Markets First Lab-on-Chip for Rapid Molecular Flu Detection at Point of Need
2. Forest Laboratories Announces Resignation of Ivan Gergel, MD
3. Dr. Wei Sun, PhD, MD Joins SpectraCell Laboratories
4. Stiefel Laboratories, Inc. Appoints New President
5. Mylan Announces Appointment of Jagdish Dore as CEO and Managing Director of Matrix Laboratories
6. IDEXX Laboratories Announces Increase in Share Repurchase Program
7. Charles River Laboratories International Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU
8. Caraco Pharmaceutical Laboratories Ltd. to Market Generic Protonix(R)
9. IDEXX Laboratories Announces Fourth Quarter Results
10. IDEXX Laboratories to Release 2007 Fourth Quarter and Full-Year Financial Results
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Metaglip(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a ... of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners ... October 11, 2017. , The annual award competition recognizes editorial and design excellence across ...
(Date:10/12/2017)... GRAND RAPIDS, Mich. (PRWEB) , ... October 12, ... ... OnSite Wellness, has been named one of Michigan’s 2017 Best and Brightest in ... Best and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: ... that developed an innovative way to use nonlinear optical ... delivery of new drugs. ... Dermatology Conference will show how researchers from BioPharmX and ... Medical School used a suite of imaging techniques in ...
(Date:10/10/2017)... Pa. , Oct. 10, 2017   West ... in innovative solutions for injectable drug administration, today shared ... West,s ID Adapter for improving the intradermal administration of ... Fourth Skin Vaccination Summit in May 2017 by Dr. ... Lead, Polio Department, World Health Organization (WHO), and recently ...
(Date:10/4/2017)... , Oct. 4, 2017 OBP ... self-contained, illuminating medical devices, today announced regulatory approval ... Surveillance Agency (or Agência Nacional de Vigilância Sanitária ... single-use, cordless surgical retractor with integrated LED light ... access, illumination and exposure of a tissue pocket ...
Breaking Medicine Technology: